SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-22-006098
Filing Date
2022-04-25
Accepted
2022-04-25 16:23:20
Documents
5
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A crsp-def_14a-2022.htm DEF 14A 3069082
2 GRAPHIC img58944232_0.jpg GRAPHIC 19505
3 GRAPHIC img58944232_1.jpg GRAPHIC 25755
4 GRAPHIC img58944232_2.jpg GRAPHIC 749585
5 GRAPHIC img58944232_3.jpg GRAPHIC 390494
  Complete submission text file 0000950170-22-006098.txt   4702893
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37923 | Film No.: 22849964
SIC: 2836 Biological Products, (No Diagnostic Substances)